Legal News

Life Sciences weekly highlights—28 May 2020

Published on: 28 May 2020
Published by: LexisPSL
  • Life Sciences weekly highlights—28 May 2020
  • In this issue:
  • Coronavirus (COVID-19)
  • MedTech statement on clinical investigations for medical device recertification amid coronavirus (COVID-19)
  • Remdesivir to be used to treat severe coronavirus (COVID-19) infection
  • Research commissioned to monitor coronavirus (COVID-19) vaccines once authorised
  • EMA calls for ‘high-quality powerful studies’ during coronavirus (COVID-19)
  • Coronavirus (COVID-19)—New legislation unnecessary for safety of NHS tracing app
  • Manufacture, marketing and sale
  • Social media advertising of prescription-only medicines
  • More...

Article summary

This week's edition of Life Sciences weekly highlights includes the latest coronavirus (COVID-19) developments, a commentary on social media advertising of prescription-only medicines, updates on the MHRA guidance for manufacturers of medical devices on field safety notices, MedTech Europe’s analysis of the impact of changes under the Medical Devices Regulation and In Vitro Diagnostic Regulation to international registrations as well as the latest Brexit news. or take a trial to read the full analysis.

Popular documents